Drug Topics April 24, 2024
Killian Meara

Sandra C. Canally, RN, found and CEO of the Compliance Team, discusses the goals, benefits, and opportunities of value-based care in pharmacy.

At the 2024 Total Pharmacy Solutions Summit Spring 2024, held April 13, Sandra C. Canally, RN, founder and CEO of the Compliance Team, hosted a session titled “Accreditation and Value-Based Care: Leveraging Operational Excellence and Clinical Services for Patients and Your Pharmacy.” In the presentation, Canally discussed the goals, benefits, and opportunities of value-based care in pharmacy, as well as how to improve operations and clinical services.

“Now, what is value-based care,” Canally asked during the session. “[It] has many different definitions. But an easy one is it’s an evolving health care model moving pharmacy from transaction-based care...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Patient / Consumer, Payment Models, Pharma, Pharma / Biotech, Provider, Trends, Value Based
Novartis to acquire radiopharmaceutical firm Mariana Oncology for up to $1.75B
Amgen shares soar as executives outline obesity drug push
A closer look at 2023's top biopharma deals and what lies ahead
Amid buzz for Amgen's obesity drug, company sees revenue boost
Fierce Pharma Asia—Ono buys Deciphera for $2.4B; Novartis expands PeptiDream collab; WuXi Bio exits BIO 2024

Share This Article